Gilead Sciences (BUE:GILD) YoY EPS Growth : 139.40% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Gilead Sciences YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Gilead Sciences's YoY EPS Growth for the quarter that ended in Mar. 2025 was 139.40%.

Gilead Sciences's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ARS1,108.68.

Gilead Sciences YoY EPS Growth Historical Data

The historical data trend for Gilead Sciences's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences YoY EPS Growth Chart

Gilead Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

-96.77

6,017.98

22.57

166.20

-76.37

Gilead Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EPS Growth	Get a 7-Day Free Trial															-1,880.53	479.92	57.00	248.50	139.40

Gilead Sciences YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Gilead Sciences's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(383.8	-	1624.5)	/	\| 1624.5 \|
=	-76.37 %

Gilead Sciences's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (Q: Mar. 2025 )
=	(Earnings per Share (Diluted) (Q: Mar. 2025 )	-	Earnings per Share (Diluted) (Q: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2024 )) \|
=	(1108.678	-	-2813.95)	/	\| -2813.95 \|
=	139.40 %

Gilead Sciences YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Gilead Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (BUE:GILD) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico 1GILD:Italy GISd:UK 0QYQ:UK GIS:Germany GILD34:Brazil GILD:Austria

Address

333 Lakeside Drive, Foster City, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).